Financial Disclosure

Boston – October 19, 2026 -- PTC (NASDAQ: PTC) will publish its fiscal 2026 fourth-quarter and full-year results on Wednesday, November 4, after the U.S. stock market closes, but the software maker has stopped earnings calls and guidance because of its pending acquisition by Schneider Electric.

PTC suspends earnings calls and withdraws guidance

PTC is suspending quarterly earnings conference calls. It also no longer provides quarterly or annual guidance. Investors will get no management commentary or forward-looking targets alongside the November 4 figures.

The company ties both changes directly to the pending transaction.

Schneider Electric agreement dates to October 5

PTC announced on October 5, 2026 that it had entered into a definitive agreement to be acquired by Schneider Electric. The source material gives no purchase price, closing timeline or regulatory conditions for the deal.

Helsinki -- Huhtamäki Oyj will publish its Q3 2026 interim report on Thursday, October 19, 2026, at approximately 8:30 EET, the company said in a release dated October 19.

Results presentation material goes live on the investor site at release

The interim report and the accompanying results presentation will be available on Huhtamaki's investor relations website once published.

CEO Ralf K. Wunderlich and CFO Thomas Geust present at 9:30 EET

Huhtamaki will hold a combined audiocast and teleconference on the same day at 9:30 EET, one hour after the report. CEO and President Ralf K. Wunderlich and CFO Thomas Geust will present the results, followed by a Q&A session. The event will be held in English and can be followed in real time.

Houston – – October 19, 2026 -- Nutex Health, Inc. (NASDAQ: NUTX) will file its Form 10-Q for the third fiscal quarter ended Sept. 30, 2026, on Thursday, Nov. 5, 2026, after the market close.

The company will issue a press release summarizing the quarterly financial results the same day.

Nutex Health schedules Nov. 6 earnings call for 9:30 a.m. CT

Management will discuss financial performance and provide a business update on Friday, Nov. 6, 2026. Participants can join through an operator using the dial-in numbers 1-877-407-9208 or 1-201-493-6784, or through an online Call meTM link that goes live 15 minutes before the start. A transcript and recording will be posted afterward in the "Investor Materials" section of the company website.

San Diego – October 19, 2026 -- The Vistage CEO Confidence Index fell 3.4 points to 80.8 in Q3 2026 from 84.2 in the prior quarter, marking the third consecutive quarterly decline in small and midsize business (SMB) CEO sentiment.

Expectations for the year ahead dropped the most. Only 19% of CEOs expect the U.S. economy to improve over the next year, down 10 percentage points from last quarter and 13 points below Q3 2025. A further 34% expect conditions to worsen, up 8 points.

Revenue hopes hold at 62%, but profit expectations lag at 47%

Some 62% of CEOs expect higher revenue, down 2 points from last quarter. Only 47% expect higher profit, as rising costs erode margins. Of those surveyed, 36% plan to increase fixed investments over the next year, down from 38% in Q2. Another 46% say U.S. economic conditions have worsened versus last year, while 14% say they have improved, down 5 points.

San Diego – October 19, 2026 -- Capricor Therapeutics (NASDAQ: CAPR) ended the second quarter with about $237.9 million in cash, cash equivalents and marketable securities, down from about $318.1 million at Dec. 31, 2025. The decline came as an FDA advisory committee voted 9 against and 3 in favor on whether evidence shows Deramiocel is effective for cardiomyopathy in Duchenne muscular dystrophy (DMD) patients.

Advisory panel vote is non-binding and limited to cardiomyopathy

The Cellular, Tissue and Gene Therapies Advisory Committee voted on July 29, 2026. Capricor says the panel was not asked to vote on the HOPE-3 primary endpoint or on overall benefit-risk. In a separate discussion of upper limb function, the committee's feedback was directionally supportive of the HOPE-3 evidence, according to the company. The recommendation is advisory and non-binding, and the Biologics License Application (BLA) remains under active FDA review.

London – October 19, 2026 -- Boots Group Finco L.P. and The Boots Group Luxco S.à r.l. have launched a consent solicitation covering €650 million of 5.375% and £375 million of 7.375% senior secured notes due 2032, offering holders a cash fee of 2.50 per 1,000 of principal for backing indenture changes tied to a pending change of ownership.

Wittington and Fairfax funds agree to acquire Boots Group parent on October 7

Oak UK Bidco Limited, owned directly or indirectly by funds linked to Wittington Investments, Limited, together with funds linked to Fairfax Financial Holdings Limited, signed a share purchase agreement on October 7, 2026. Under it, the buyer will acquire all issued and outstanding ordinary shares of Blazing Star Boots Superco (Jersey) Limited from The Boots Group Limited. Completion is expected in the first half of 2027, though the agreement allows that date to be extended.

Stockholm – October 19, 2026 -- Ericsson now holds 129,915,894 Class B shares in treasury after repurchases made between October 12 and October 16, 2026, under its SEK 15 billion buyback program.

Ericsson runs the SEK 15 billion program through March 2027

The program was announced on April 16, 2026. It runs from April 23, 2026, until March 31, 2027, at the latest. The weekly disclosure covers purchases of Class B shares (ISIN: SE0000108656). The source text does not include the volumes or prices for the week, which are given in an attached breakdown.

Goldman Sachs Bank Europe executes all trades on Nasdaq Stockholm

Goldman Sachs Bank Europe SE carried out all acquisitions on Nasdaq Stockholm on behalf of Ericsson. The program follows Regulation (EU) No 596/2014 on market abuse and Commission Delegated Regulation (EU) 2016/1052, known as the Safe Harbour Regulation.

Manila – October 19, 2026 -- Salmon Group, a technology-driven banking and lending platform in the Philippines, has secured an additional $140 million in financing to expand its lending operations in the country.

Financing combines $90 million in commitments with $50 million in bond proceeds

The round consists of $90 million committed by Spice Expeditions, WashU and Moore, plus $50 million of bond proceeds.

Proceeds will fund the scaling of profitable lending, specifically the Salmon Credit Line and in-store lending. They will also finance the nationwide roll-out of new products, including motorcycle and MSME lending.

Salmon reaches 9 million app downloads in under four years of operations

Salmon operates through two licensed entities: Salmon Bank (Rural Bank), licensed by the BSP, and Salmon Finance, licensed by the SEC. The company describes itself as one of the fastest-growing technology companies in the Philippines.

Stockholm – October 19, 2026 -- Truecaller expects third-quarter 2026 net sales of SEK 464 million (468), a 3% rise in constant currencies year over year and an 18% increase on the second quarter, according to preliminary unaudited figures.

Ad revenue falls 12% year over year but rebounds 23% on the quarter

Ad revenues are expected at SEK 245.6 million (290.2), down 12% in constant currencies from the third quarter of 2025 and up 23% from the previous quarter. CEO Rishit Jhunjhunwalam said the company is moving to its own ad platform and auction process, and revenue improved gradually during the quarter.

Premium revenue jumps 32% to SEK 127.1 million

Premium revenues are expected at SEK 127.1 million (96.4), up 32% in constant currencies year over year. Truecaller for Business is expected to bring in SEK 85.1 million (79.9), up 14% in constant currencies year over year and 15% on the previous quarter.

Boston – October 19, 2026 -- Aura (ASX: AXQ) will release its Q3 2026 financial results on Thursday, Nov. 12, 2026, before the ASX market opens, and will hold a webcast at 10:30am AEDT the same day to discuss results and business outlook.

Appendix 4C and activities report due Oct. 30

The online safety and wellbeing company will file its Appendix 4C and Quarterly Activities Report for the quarter ended Sept. 30, 2026, on Friday, Oct. 30. That filing comes 13 days before the full Q3 results.

Webcast set for 6:30pm EST on Nov. 11 for U.S. investors

The earnings call starts at 10:30am AEDT on Nov. 12, which is 6:30pm EST on Nov. 11. Aura will post a replay on its investor relations website. Registration for the live session is handled through an online event platform.

William Lundregan, Chief Legal Officer and Secretary, authorized the announcement.